GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (XSWX:BMY) » Definitions » Cyclically Adjusted PB Ratio

Bristol-Myers Squibb Co (XSWX:BMY) Cyclically Adjusted PB Ratio : (As of May. 18, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.35 5.50 4.95 5.23 3.52

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.91 4.45 3.99 3.52 3.68

Competitive Comparison of Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio falls into.



Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bristol-Myers Squibb Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.597/131.7762*131.7762
=6.597

Current CPI (Mar. 2024) = 131.7762.

Bristol-Myers Squibb Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 8.282 100.560 10.853
201409 8.554 100.428 11.224
201412 8.763 99.070 11.656
201503 9.138 99.621 12.088
201506 8.453 100.684 11.063
201509 8.790 100.392 11.538
201512 8.547 99.792 11.286
201603 8.455 100.470 11.090
201606 8.656 101.688 11.217
201609 9.092 101.861 11.762
201612 9.910 101.863 12.820
201703 8.764 102.862 11.228
201706 8.677 103.349 11.064
201709 8.693 104.136 11.000
201712 7.131 104.011 9.035
201803 7.420 105.290 9.287
201806 7.472 106.317 9.261
201809 8.092 106.507 10.012
201812 8.570 105.998 10.654
201903 9.308 107.251 11.437
201906 9.694 108.070 11.821
201909 10.730 108.329 13.052
201912 22.756 108.420 27.658
202003 21.160 108.902 25.605
202006 20.721 108.767 25.104
202009 20.307 109.815 24.368
202012 15.129 109.897 18.141
202103 15.743 111.754 18.563
202106 15.045 114.631 17.295
202109 15.462 115.734 17.605
202112 14.906 117.630 16.699
202203 13.215 121.301 14.356
202206 14.241 125.017 15.011
202209 14.317 125.227 15.066
202212 13.029 125.222 13.711
202303 13.261 127.348 13.722
202306 12.962 128.729 13.269
202309 11.745 129.860 11.918
202312 11.459 129.419 11.668
202403 6.597 131.776 6.597

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bristol-Myers Squibb Co  (XSWX:BMY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (XSWX:BMY) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.